pteridines has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichinose, H | 1 |
| Inoue, KI | 1 |
| Arakawa, S | 1 |
| Watanabe, Y | 1 |
| Kurosaki, H | 1 |
| Koshiba, S | 1 |
| Hustad, E | 1 |
| Takada, M | 1 |
| Aasly, JO | 1 |
1 other study available for pteridines and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Animals; Biomarkers; Female; Heterozygote; Humans; Leucine-Rich Repe | 2018 |